ClinicalTrials.Veeva

Menu

Human and Microbial Determinants of the Onset of IBD Flares

Viome logo

Viome

Status

Enrolling

Conditions

IBD (Inflammatory Bowel Disease)

Study type

Observational

Funder types

Other
Industry

Identifiers

Details and patient eligibility

About

This study will collect longitudinal biological samples and survey data to identify the triggers of IBD flares.

Full description

This is a longitudinal observational study whose goals are to identify:

Microbial and human molecular triggers of IBD relapses, Microbial and human molecular pathways strongly associated with flares that could be targeted with nutrition with a therapeutic potential, Biomarkers of IBD for Dx purposes, Identify microbial functions associated with release of BH4.

Enrollment

100 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patient at Universidade Federal de Santa Catarina (UFSC) Hospital, under care of Dr. Vivian Menegassi

Exclusion criteria

  • Cancer Diagnosis/Treatment
  • Under 18 years old

Trial design

100 participants in 1 patient group

Inflammatory Bowel Disease (IBD)
Description:
Individuals diagnosed with IBD

Trial contacts and locations

1

Loading...

Central trial contact

Raquel Clinical Research Coordinator; Momo Vuyisich Chief Science Officer, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems